A 120-kD glycoprotein antigen abundantly expressed on BWastomyces dermatitidis yeasts is a target of cellular and humoral immune responses in human infection. To investigate the antigen and immune response more carefully at the molecular level, we screened an expression library from B. dermatitidis to identify clones that encode this antigen, designated WI-1. A 942-bp cDNA was isolated by immunologic screening with polyclonal, rabbit anti-WI-i antiserum. Northern hybridization analysis showed that the cDNA hybridized to yeast message _ 3.9 kb. DNA and deduced protein sequence analysis of the clone demonstrated a 25-amino acid repeat arrayed in tandem, present in 4.5 copies near the 5' end, and rich in predicted antigenic epitopes. Further analysis showed strong homology in these tandem repeats with invasin, an adhesin of Yersiniae. Cloned cDNA was used to express a 30-kD fusion protein strongly recognized in western blots by rabbit anti-WI-i antiserum, and by sera from all 35 blastomycosis patients studied. The fusion protein product of subcloned cDNA encoding only the tandem repeat also was strongly recognized in western blots by sera from the 35 blastomycosis patients, but not by sera from 10 histoplasmosis and 5 coccidioidomycosis patients. An antigeninhibition radioimmunoassay showed that the tandem repeat alone completely eliminated rabbit and human anti-WI-i antibody binding to radiolabeled native WI-1. From these results, we conclude that the 25-amino acid repeat of WI-1 displays an immunodominant B cell epitope, and that the carboxyl-terminus of the molecule exhibits an architecture that may promote adhesion of Blastomyces yeasts to host cells or extracellular matrix proteins and ultimately provide a clearer picture of the molecular pathogenesis of blastomycosis. (J. Clin. Invest.
Introduction
Blastomycosis, an endemic systemic mycosis accompanied by protean manifestations involving the lung, skin, bone, genitourinary tract, and brain, results from infection with the thermal dimorphic fungus Blastomyces dermatitidis. Humans and lower animals such as dogs are primarily infected by inhaling aerosolized conidia from soil, where the organism dwells as a saprophyte. At body temperature, the conidia convert to the parasitic or invasive yeast forms that cause disease.
A lack of understanding of the antigens of B. dermatitidis yeasts has hampered the development of reliable assays for diagnosis and study of immunologic features ofblastomycosis. We recently described a novel 120-kD surface protein abundantly expressed on B. dermatitidis yeasts (1) and have demonstrated that the antigen is a target of antibody (1) and cell-mediated immune responses in infected humans (2) . Based on these observations, we developed a radioimmunoassay to reliably diagnose infection by detecting antibody against the protein and have characterized T cells directed against processed forms of the protein in the course of human disease. Results from these preliminary studies indicate that the antigen holds considerable promise for improved diagnosis and study of the immunologic features of blastomycosis.
In our initial work with the 120-kD antigen, which we have designated WI-1, we employed crude techniques to isolate small amounts of partially purified protein and provided limited characterization of the molecule. In the present paper, we report the cloning of cDNA encoding a portion of WI-1. In addition to providing an abundant source ofrecombinant antigen and detailed structural information about the molecule, our work demonstrates that the carboxyl-terminus ofWI-1 encompasses antigen-rich, tandem repeats and an immunodominant epitope against which human B cell responses are directed.
Methods
Fungi. American Type Culture Collection (ATCC) strains 60636 and 26199 were used for these studies (ATCC, Rockville, MD). These represent virulent isolates that have been associated with human disease. Stock cultures were maintained in the yeast form on 7H10 agar enriched with oleic acid-albumin complex (Sigma Chemical Co., St. Louis, MO) at 37°C. Yeasts were grown in Erlenmeyer flasks containing brain heart infusion (BHI) broth (Difco Laboratories, Detroit, MI) at 370C in a gyrator shaker at 120 rpm for 72 h. Cells were harvested by filtration through a sintered glass filter and washed with saline.
Extraction of RNA and synthesis of cDNA. Total RNA was extracted from freshly grown B. dermatitidis yeasts using a phenol-chloroform technique (3) . Diethylpyrocarbonate (DEPC)-treated water and RNAse-free glassware and plasticware were used for extracting, purifying, and analyzing RNA. A 10-g wet-wt pellet of yeasts was suspended in 10 ml lysis buffer (0.1 M Tris, 0.1 M lithium chloride, 0.01 M dithiothreitol, pH 7.0). The cell suspension was transferred to a prechilled metal cannister containing 10 ml 0.45-0.50-mm glass beads, 15 ml phenol-chloroform-isoamyl alcohol (24:24:1), and 2 Starting with 5 gg poly (A)' RNA from strain 60636, first-and second-strand cDNA were synthesized using murine maloney leukemia virus reverse-transcriptase, oligo (dT) primer, and other reagents and methods specified in a commercial synthesis kit (Pharmacia LKB Biotechnology, Piscataway, NJ). The ends of double-stranded cDNA were filled in with Klenow fragment and ligated to EcoRI/NotI adaptors with the sequence d(5'-AATTCGCGGCCGC-3'). Sephacryl S-400 spun columns (Pharmacia LKB Biotechnology) were used to purify cDNA fragments > 400 bp. Each aliquot ofcDNA was ligated into 100 ng of a dephosphorylated phagemid vector, pBluescript II (KS') (Stratagene, La Jolla, CA), which contains transcriptional and translational start sequences from the lac Z gene. After ligation, cDNA was electroporated into competent Escherichia coli XL 1-Blue (Stratagene), which were prepared as described (5) .
Screening the cDNA expression library with antibody and colony hybridization. Transformed E. coli were plated on LB agar in 150-mmdiameter petri plates (Falcon Plastics, Cockeysville, MD). After overnight growth at 37°C, bacteria were replica-plated onto a fresh agar plate, and onto a 150-mm nitrocellulose sheet (Schleicher & Schuell, Inc., Keene, NH). After colonies grew to 1-2 mm on nitrocellulose, the filter was transferred to a fresh LB agar plate supplemented with 5 mM isopropylthiogalactoside (IPTG)' and incubated for an additional 2-4 hours. Bacteria on the filters were lysed and the filters processed for immunoscreening as described (6) . Rabbit antiserum specific for WI-I (anti-WI-I titer, 1:10,240, as measured by radioimmunoassay [1] ) was used to screen a portion ofthe expression library. The serum was preabsorbed with E. coli lysate (Promega Biotec, Madison, WI) overnight at 4°C. Preliminary experiments determined that preabsorbed antiserum diluted 1:2,000 could discriminate 50 ng WI-I spotted onto nitrocellulose from background staining of lysed E. coli proteins on the filter. Immunoscreening was performed with this antiserum according to previously described methods (6) . Rabbit anti-WI-I bound to nitrocellulose was detected with goat anti-rabbit immunoglobulin G conjugated with alkaline phosphatase (Promega Biotec). Positive colonies were isolated from original replica plates, replated, and rescreened with antibody until they were purified.
A 942 bp WI-l-cDNA identified through immunoscreening was used subsequently to screen the library by colony hybridization to attempt to identify additional, longer cDNAs. The entire 942-bp fragment was removed from the vector by digestion with NotI (Bethesda Research Laboratory, Gaithersburg, MD), and purified from low melting point agarose (Bethesda Research Laboratory) using Geneclean (BIO 101, Inc., La Jolla, CA). A 100-ng aliquot of the fragment was radiolabeled with [a-32P]dCTP to a specific activity of 109 cpm/ug using random oligonucleotides as primers (IBI-Kodak Co. New Haven, CT). Colony hybridization was performed as described (6) . Positive colonies were isolated from original replica plates, replated, and rescreened with probe until they were purified.
Northern hybridizations. Total RNA samples (20 Ag) were electro- (9) . Gels were stained for protein with Coomassie brilliant blue.
To assess antibody recognition of the fusion protein, western blots of gels were prepared as described (10) . Human antisera used in these experiments were from blastomycosis patients in whom antibody responses to WI-i had previously been demonstrated by RIA (1) , and from seronegative control subjects with other fungal diseases or no illness. Sera had been stored at -70°C for up to 8 y prior to testing.
The fusion protein was electroeluted from polyacrylamide gels using an electrophoretic concentrator (Isco, Inc., Lincoln, NE) as described (1) for further immunologic studies. To determine the relative importance of immunologic determinants on the fusion protein, an antigen-inhibition RIA was used. It examined the ability of samples of eluted protein or crude E. coli lysate to block anti-WI-I antibody binding to radiolabeled WI-1. Briefly, RIAs were constructed using 0. 1-5 ng radiolabeled WI-I as a target. Assays were done in 12 X 75 mm acidwashed glass tubes. We used 0.1% BSA in 0.04 M Na phosphate, 0.15 M NaCl, pH 7.5 (BSA-PBS) as a carrier solution. Each experimental or control sample was analyzed in duplicate or triplicate. A test sample consisted of0.1 ml ofdiluted serum and 0.1 ml ofradiolabeled antigen. When an antigen-inhibition RIA was done, 0.1 ml of the inhibitor or BSA-PBS was added to diluted antibody in appropriate tubes. All tubes were incubated 4-18 h at 40C before radiolabeled antigen was added. For each antigen-inhibition RIA performed, a preliminary RIA was done to determine the dilution of serum that bound -50% of radiolabeled antigen target. This dilution of serum was added to tubes of the antigen-inhibition RIA. For RIAs and antigen-inhibition RIAs, 2 mg insoluble staphlococcal protein A (Sigma Chemical Co.) was added to each sample and control tube after overnight incubation at 4VC. Precipitates were centrifuged at 2,000 g for 10-40 min and a volume ofsupernatant was removed from each tube for counting in a gamma counter. We corrected for coprecipitation in RIAs by the method ofMinden and Farr (1 1 bp and contain the common enzyme restriction site for EcoRI. Northern hybridizations using WI-1 cDNA to probe B. dermatitidis RNA illustrate that the full-length message for WI-1 is -3.9 kb (Fig. 1) . WI-1 message is abundantly expressed in the yeast strain 60636, from which the partial cDNA was cloned, as well as in the unrelated strain 26199 (data not shown).
WI-I cDNA sequence. DNA sequence analysis ofthe largest clone isolated by immunoscreening is shown in Fig. 2 lanei. teins that confer adhesion to cells or extracellular matrix ( 13) . This similarity with EGF-like domains expressed in at least seven other proteins is not likely due to chance alone (P values ranging from < 1.7 X 10-8 to < 0.01), according to a recently described algorithm (14) .
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The predicted structure and antigenicity of the protein encoded by the WI-1 insert was analyzed using algorithms of Chou and Fasman (15) 24-20-bic region. Residues in this area are predicted to form a betapleated sheet, a common structural motifof EGF-like domains based on conserved sequence and dictated by the position of the disulfide bonds (13) . In contrast, residues in each region showing similarity with invasin are predicted to form several turns and an a helix at the initiation. The 25-amino acid repeat arrayed in tandem folds back on itself several times, and these repeats, which also encompass the invasin-like domains, are packed with predicted antigenic sites.
Expression of the fusion protein.
Lysates of E. coli XLlblue transformed with the pBluescript II vector alone or the vector plus 942-bp WI-1 insert, studied by SDS-PAGE, show that a fusion protein of -30 kD is expressed by 2 h and produced maximally by 4 h after induction with IPTG (Fig. 4 A,  lane 2, see arrow) . This protein may represent WI-1 cleaved from the 3.5 kD (3-galactosidase fusion partner, since the same lysate also contains smaller amounts of 33.5 kD protein that is enriched in comparison to control lysates. Rabbit anti-WI-1 specifically recognizes both of these proteins in a western blot (Fig. 4 B) .
Human immune responses to WI-I fusion proteins. 46 sera from 35 patients with culture-confirmed cases ofblastomycosis were tested for recognition of proteins in the E. coli lysates. 19 (54%) of the patients had isolated pulmonary disease, the remainder had disseminated disease involving skin alone (8 patients); lung and skin (5); lung, skin, and brain (1); brain alone (1); and eye alone (1). Titers of antibody to WI-1 in these patients ranged from 1:100 to 1:34,000 (geometric mean titer, 1:850). All sera tested reacted specifically with WI-1 fusion protein in Western blots (Fig. 5) . Some background reactivity with E. coli proteins in the lysates is seen in all lanes of the blots. Preabsorption of rabbit and human anti-WI-1 antisera with either the eluted fusion protein or with E. coli lysate containing the fusion protein nearly eliminated recognition of radiolabeled WI-1 in the RIA, whereas preabsorption with E. coli lysate without the fusion protein had no influence on WI-1 recognition (Fig. 6, A and B) . The fusion protein further inhibited anti-WI-1 binding to '251-WI-1 in a dose-dependent manner (Fig. 6, C (Fig. 7) . Sera from the 35 blastomycosis patients studied above were examined for recognition of the tandem repeat by Western blot. All ofthem reacted strongly with the recombinant protein (Fig. 8) . None ofthe sera from ten patients with histoplasmosis nant protein, although some background reactivity with E. co/i proteins in the lysates is evident (Fig. 8) .
To assess the relative importance of the tandem repeat in antibody recognition of WI-1, we tested the 21 -kD fusion protein in the antigen-inhibition RIA using anti-WI-I antisera from ten blastomycosis patients and an immunized rabbit. The tandem repeat inhibited a mean of96% (range 85-100%) ofthe antibody binding to radiolabeled WI-I in the blastomycosis patients, and 87% of the binding of antibody in the immune rabbit (Fig. 9) . The results were uninfluenced by whether the fusion protein was tested after purification by elution, or in the presence of E. coli lysate, whereas E. coli lysate alone without the fusion protein had no influence whatsoever on anti-WI-I antibody binding of radiolabeled WI-1.
Discussion
The diagnosis and basic investigation of blastomycosis has been seriously hampered by the lack of well-defined antigens. We recently described a novel antigen, WI-1, a 120-kD glycoprotein that is abundantly displayed on the surface of B. der-I I I EL-n E-.oi 21 2) . Because of the possible importance of WI-l with respect to improved serodiagnosis, study of host-pathogen interactions, and understanding of the biology of the fungus, we have sought to learn more about this antigen at the molecular level.
In this report, we describe the cloning of cDNA that encodes a portion of WI-1. Several lines of evidence support this conclusion. First, rabbit anti-WI-1 antiserum was used to screen an expression library for clones that produce immunoreactive protein, and the cDNA isolated and characterized produces a fusion protein that reacts specifically and strongly with rabbit antiserum in both a Western blot and radioimmunoassay. Second, antisera from blastomycosis patients with high antibody titers to native WI-1 also react strongly and specifically with the fusion protein in both of these assays, whereas sera from 15 histoplasmosis or coccidioidomycosis control subjects do not. Although the number of controls studied here is limited, the specificity is consistent with previous work, in which only two (3%) of 73 control subjects with other fungal infections had detectable antibody to radiolabeled, native WI-1 (1). Third, the results of analysis of the DNA sequence and deduced amino acid sequence of the cDNA are remarkably consistent with previous analysis of the amino acid composition of native WI-1, such as the high content of aromatic residues and especially the unusually large amount of cysteine (Klein, B ., manuscript in preparation). Finally, northern hybridization using the cloned cDNA probe identifies a message -3.9 kb, approximately the size predicted for native WI-1. Despite these lines of evidence, formal proof that we have isolated WI-1 cDNA awaits a comparison of the DNA sequence with amino acid sequence from native WI-1. In view of this fact, it may be appropriate to refer to the cDNA and recombinant protein we describe as a WI-1-like antigen sequence.
The cDNA clone studied encodes only a portion of WI-1. The uniformity in size of about I kb for nearly all the independently derived cDNA clones is quite striking, and suggests that RNA secondary structure may interfere with transcription beyond this point. This conclusion is supported by previous difficulties we have had with in vitro translation of heat-denatured Blastomyces total or poly (A)' mRNA: Methyl mercury hydroxide denaturation of RNA secondary structure was required to produce large (although still incomplete) translation products (Klein, B., and J. Jones, manuscript submitted for publication). Secondary structure commonly interferes with the cloning of full-length cDNAs (6, 17) . Preliminary evidence has indicated that we can use a custom primer derived from the WI-1 cDNA sequence, rather than oligo (dT)121,8, to transcribe beyond the presumed, problematic area of secondary structure and isolate larger cDNAs.
The truncated form of recombinant WI-1 produced by the cloned cDNA appears to be highly antigenic and to contain an immunodominant region for antibody recognition by infected humans. The fusion protein contains 219 amino acids at the carboxy terminus ofWI-1. Chou-Fasman predictions based on the deduced amino acid sequence of the fusion protein (15) indicate that the 25-amino acid tandem repeat is rich in antigens, probably B cell epitopes. These predictions are based principally on the hydrophilic character, and exposed and accessible highly charged and polar residues, that appear to comprise the turns and a helices within this repeat. Our results with human anti-WI-1 antisera are consistent with these predictions. All patients tested strongly and specifically recognized the fusion protein in Western blots, and nearly all antibody reactivity against WI-1 could be removed from antiserum by preabsorption with the fusion protein in the RIA. Our experimental results further delineate the antibody recognition site to within the tandem repeat ofthe fusion protein. Precise identification of the residues that comprise the epitope should be relatively straightforward with the preparation of synthetic peptides or deletion mutants of WI-1 cDNA.
The theme of immunodominant B cell epitopes contained within multiple repeats arrayed in tandem on microbial antigen has previously been described in a conserved antigenic epitope of Trypanosoma cruzi (18) and in the circumsporozoite antigen ofPlasmodiumfalciparum (19) . The importance ofthe strong immune response directed against these determinants remains unclear. Nonetheless, identification of the immunologic importance of the tandem repeat on WI-1 will permit improved serodiagnosis of blastomycosis. This issue notwithstanding, it is well accepted that antigen-specific T cells confer acquired resistance and protect against a lethal challenge of Blastomyces in animal models (20) . We The EGF-like domain in WI-I cDNA consists of a singlecopy homologue ofthe EGF repeat unit, which preserves many of the Cys or Gly residues characteristic of the structure, and particularly the presence of two antiparallel ,3-strands between Cys 3 and Cys 4 believed to comprise the EGF receptor recognition site (13) . We recognize that only five of six consensus cysteines in this motif are apparent in WI-I and that the alignment ofthese conserved residues is not precise when compared to the EGF consensus sequence. However, the spacing of conserved residues typically varies in EGF-like domains so that at least three types of consensus sequences have been described (13) . When compared to other molecules containing EGF-like domains, WI-I shows the best fit with the repeats of lymph node homing receptor (26) , uromodulin (27) , nidogen (28) , and fibulin, each ofwhich governs diverse cell-cell or cell-matrix interactions. This observation, taken together with the close proximity of the EGF repeat and multiple invasin-like domains, would support the notion that the carboxy terminus of surface exposed WI-I may promote adhesion of Blastomyces yeasts to host cells or extracellular matrix proteins. Preliminary experiments indeed have shown that WI-I functions as an adhesion-promoting protein and mediates the binding of yeasts to mammalian cells. Study and further clarification of the role of WI-I in these interactive events may provide a clearer picture of the molecular pathogenesis of blastomycosis.
